Amedisys Inc
NASDAQ:AMED

Watchlist Manager
Amedisys Inc Logo
Amedisys Inc
NASDAQ:AMED
Watchlist
Price: 89.96 USD 4.67% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Amedisys Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one AMED stock under the Base Case scenario is 133.11 USD. Compared to the current market price of 89.96 USD, Amedisys Inc is Undervalued by 32%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AMED Relative Value
Base Case
133.11 USD
Undervaluation 32%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.3
P/S
P/S
Price to Sales
1.3
vs History
73
vs Industry
58
Median 3Y
1.4
Median 5Y
1.9
Industry
2.3
Forward
1.2
More Details
35.5
P/E
P/E
Price to Earnings
35.5
vs History
39
vs Industry
0
Median 3Y
25.6
Median 5Y
34.5
Industry
23.2
Forward
20.1
More Details
13.9
P/OCF
P/OCF
Price to OCF
13.9
vs History
95
vs Industry
12
Median 3Y
23.7
Median 5Y
26.1
Industry
14.3
More Details
20.1
P/FCFE
P/FCFE
Price to FCFE
20.1
vs History
61
vs Industry
15
Median 3Y
35
Median 5Y
31.5
Industry
20.1
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
85
vs Industry
29
Median 3Y
2.9
Median 5Y
4.2
Industry
2.2
More Details
1.3
EV/S
EV/S
Enterprise Value to Sales
1.3
vs History
88
vs Industry
57
Median 3Y
1.5
Median 5Y
2
Industry
2.4
Forward
1.3
More Details
3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3
vs History
88
vs Industry
56
Median 3Y
3.4
Median 5Y
4.5
Industry
5
More Details
13
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13
vs History
92
vs Industry
21
Median 3Y
15.4
Median 5Y
16.8
Industry
12.8
Forward
11.9
More Details
14.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
14.6
vs History
93
vs Industry
24
Median 3Y
17.3
Median 5Y
18.9
Industry
17.2
Forward
13.3
More Details
14.4
EV/OCF
EV/OCF
Enterprise Value to OCF
14.4
vs History
95
vs Industry
12
Median 3Y
26.5
Median 5Y
27.9
Industry
14
More Details
15
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
15
vs History
95
vs Industry
12
Median 3Y
28
Median 5Y
29.6
Industry
18.2
More Details
1.6
EV/IC
EV/IC
Enterprise Value to IC
1.6
vs History
71
vs Industry
41
Median 3Y
1.8
Median 5Y
2.4
Industry
1.9
More Details

Multiples Across Competitors

AMED Competitors Multiples
Amedisys Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Amedisys Inc
NASDAQ:AMED
2.9B USD 1.3 35.5 13 14.6
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
Cigna Corp
NYSE:CI
77.9B USD 0.3 25.6 8 10.3
US
CVS Health Corp
NYSE:CVS
56B USD 0.2 11.2 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
26B EUR 1.3 49 11.2 25.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.9B EUR 0.9 -49.2 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.3 13.2 20.4
US
R1 RCM Inc
NASDAQ:RCM
17.7B USD 7.2 -289.7 38.3 99.1
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.4 12.3 16.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR 0.7 24.5 7.1 16.4
US
DaVita Inc
NYSE:DVA
12.7B USD 1 15.4 8 11.1
P/E Multiple
Earnings Growth PEG
US
Amedisys Inc
NASDAQ:AMED
Average P/E: 28
35.5
N/A N/A
US
C
Cigna Group
XMUN:CGN
25.9
25%
1
US
Cigna Corp
NYSE:CI
25.6
25%
1
US
CVS Health Corp
NYSE:CVS
11.2
3%
3.7
DE
Fresenius Medical Care AG
XMUN:FME
49
31%
1.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49.2 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.3
54%
0.8
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -289.7
253%
N/A
US
Quest Diagnostics Inc
NYSE:DGX
20.4
12%
1.7
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
24.5
31%
0.8
US
DaVita Inc
NYSE:DVA
15.4
17%
0.9

See Also

Summary
AMED intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMED stock valuation using valuation multiples.
Wall Street Estimates
AMED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.